MacBeath Gavin
Insider CIK 1738082 · TCRX See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TCRX TScan Therapeutics, Inc. | A Award | 2026-10-01 | 2026-10-02 | 1,000,000 | — | $0 | 1,049,767 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2026-01-20 | 2026-01-22 | 1,165,000 | — | $0 | 1,165,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-02-11 | 800,000 | — | $0 | 800,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2024-01-12 | 2025-02-11 | 160,000 | — | $0 | 160,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 1,121,300 | — | $0 | 1,121,300 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2022-07-25 | 2022-07-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2021-09-21 | 2021-09-22 | 57 | $6.19 | $353 | 49,767 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2021-09-20 | 2021-09-22 | 4,943 | $6.22 | $30.7K | 49,710 | SEC↗ |